Online citations, reference lists, and bibliographies.

Neopterin As A Potential Modulator Of Tumor Cell Growth And Proliferation.

J. Rieder, P. Lirk, G. Hoffmann
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
The present article proposes tumor-promoting biochemical effects of the immunologically active pteridine-compound neopterin. Based on previous findings of interactions between neopterin and the cellular redox state, two major pathways of tumor progression are presented: (1) the inhibition of nitric oxide-induced apoptotic death of tumor cells via suppression of nitric oxide synthesis in the presence of neopterin; (2) the stimulatory effects of neopterin on the production and release of angiogenic growth factors. High serum neopterin concentrations are a common finding in tumor patients and correlate well with the fatal outcome of the disease. Affection of tumor tissue growth as well as formation of metastases by neopterin may provide an explanation for these clinical observations.
This paper references
The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
J. Frick (1985)
Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature
S. P. Andrade (1992)
Neopterin and 7,8‐dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2
W. Schobersberger (1996)
Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells.
G. Hoffmann (1998)
Abstracts.Twentieth International Winter-Workshop on Clinical, Chemical, and Biochemical Aspects of Pteridines
E. Artner-Dworzak (2001)
Effect of neopterin and 7,8‐dihydroneopterin on tumor necrosis factor‐α induced programmed cell death
G. Baier-Bitterlich (1995)
Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.
S. Mesiano (1998)
Neopterin modulates toxicity mediated by reactive oxygen and chloride species
G. Weiss (1993)
Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
G. Reibnegger (1987)
The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases.
D. Fuchs (1992)
Erythropoietin receptor mRNA expression in human endothelial cells.
A. Anagnostou (1994)
The prognostic value of nuclear roundness and neopterin in ovarian cancer.
C. Marth (1993)
Neopterin activates transcription factor nuclear factor‐κB in vascular smooth muscle cells
G. Hoffmann (1996)
Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines.
J. Rieder (2000)
Inhibition of angiogenesis, tumour growth and metastasis by the NO‐releasing vasodilators, isosorbide mononitrate and dinitrate
E. Pipili-Synetos (1995)
Neopterin derivatives modulate the nitration of tyrosine by peroxynitrite.
B. Widner (1998)
Suppressive Effects of Neopterin on Inducible Nitric Oxide Synthase Gene Expression in Ovarian Carcinoma Cells in vitro
J. Rieder (2001)
Neopterin–Induced Tumor Necrosis Factor–· Synthesis in Vascular Smooth Muscle Cells in vitro
G. Hoffmann (1998)
Urinary neopterine as marker for haematological neoplasias.
A. Hausen (1981)
Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.
A. Anagnostou (1990)
Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines.
J. Rieder (2001)
Neopterin-induced Suppression of Erythropoietin Production In Vitro
W. Schobersberger (1995)
Apoptosis in the pathogenesis and treatment of disease
C. Thompson (1995)
Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells
W. Schobersberger (1995)
Serum neopterin levels in patients with hepatocellular carcinoma.
S. Antoniello (1992)
Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
M. Haeger (1996)

This paper is referenced by
Metal complexes with the ligand derived from 6-acetyl-1,3,7-trimethyllumazine and benzohydrazide. Molecular structures of two new Co(II) and Rh(III) complexes and analysis of in vitro antitumor activity.
Sonia B. Jiménez-Pulido (2008)
7,8-Dihydroneopterin-mediated protection of low density lipoprotein, but not human macrophages, from oxidative stress
Carole A Firth (2006)
Concentrations of Neopterin and Interleukin-10 in Peritoneal Fluid and in Serum of Women with Endometriosis
Z. Kondera-Anasz (2004)
Synthesis, Tautomerism, and Antiradical Activity of Novel Pteridinetrione Derivatives
M. S. Kazunin (2018)
Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Lukas Lanser (2020)
Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.
Carole A Firth (2008)
Nitric oxide may directly induce the psoriatic disease process via suppression of keratinocyte apoptosis and induction of keratinocyte hyperproliferation
M. Namazi (2017)
Macrophage antioxidant protection within atherosclerotic plaques.
S. Gieseg (2009)
Influence of surgical trauma on neopterin concentrations in gastric carcinoma patients.
A. Engin (2010)
Socioeconomic status and health: exploring biological pathways
R. Lucas (2003)
Influence of Surgical Trauma on Neopterin Concentrations in Gastric Carcinoma Patients
A. Engin (2010)
Semantic Scholar Logo Some data provided by SemanticScholar